Seventh Annual PharmaCongress: Agenda: Preconference Symposia

	Preconference Symposia - Wednesday, November 8, 2006

	7:00 a.m.			Congress Registration
	8:30 a.m.			Preconferences Commence; Choose one only
	Preconference I			Pharmaceutical Compliance Current Trends: Hot Button Issues to Look at this Year in Sales, Marketing, Clinical, Medical Affairs and Government Pricing Sales and Marketing - Are We OK? John Alivernini, Vice President and Chief Compliance Officer, Wyeth Pharmaceuticals, Collegeville, PA Paul J. Silver, Managing Director, Life Sciences Leader, Huron Consulting Group, Atlanta, GA Presentation Material (Acrobat) Presentation Material (Powerpoint) Clinical and Medical Affairs - The Current Trends and Hot Issues Mark A. DeWyngaert, MBA, Ph.D., Managing Director, Huron Consulting Group, New York, NY Craig A. Metz, Ph.D., Vice President CEDD Regulatory Affairs, GlaxoSmithKline, Research Triangle Park, NC Government Pricing and Commercial Contracting - Big Changes Coming Debjit Ghosh, Director, Pharmaceuticals and Health Plans Practice, Huron Consulting Group, New York, NY Tim Nugent, Managing Director, Huron Consulting Group, LLC, New York, NY
	Preconference II			Compliance in a Highly Litigious World: Creating Good Documents and Avoiding Bad Ones William T. Fitzgerald, Vice President, Global Compliance, Alcon Laboratories, Fort Worth, TX Richard L. Scheff, Esq., Partner and Chairman, Litigation Department, Montgomery, McCracken, Walker & Rhoads, LLP, Former Chief of the Corruption/Labor Section, U.S. Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA Presentation Material (Acrobat) Microsoft Powerpoint Version too large to post Roy Speed, President, Salient, Inc., Author, Bad Documents: Business Writing in a Litigation Age, Bethel, CT Presentation Material (Acrobat) Presentation Material (Powerpoint)
	Preconference III			Advanced Tactics for Negotiation with the Government and Preparing for a CIA Indrani M. Franchini, Esq., Deputy Compliance Officer, Worldwide Programs, Senior Corporate Counsel, Corporate Compliance, Pfizer Inc., New York, NY Wendy C. Goldstein, Esq., Partner, Epstein Becker & Green, New York, NY Elizabeth Lewis, Esq., Associate General Counsel, Commercial, Millennium Pharmaceuticals, Inc., Cambridge, MA John Rah, Esq., Partner, Epstein Becker & Green, Washington, DC Lynn Shapiro Snyder, Esq., Partner, Epstein Becker & Green, Washington, DC (Moderator) Handout Material (Acrobat) Handout Material (Microsoft Word)
	Preconference IV			Powerful Business Writing: Capture, Persuade and Motivate Linda Rivero, Founder and President, Voice of Persuasion, Former Adjunct Professor of Language, State University of New York and Iona College, Alexandria, VA Nancy Singer, Esq., President, Compliance-Alliance, LLC, Former Special Counsel, AdvaMed, Founder, AdvaMed Medical Technology Learning Institute, Arlington, VA
	Noon			Preconference Adjournment: Lunch on your Own


	Pharma Congress Day One - Wednesday, November 8, 2006

1:00 p.m.

Welcome and Annual State of the Pharmaceutical Compliance Enterprise Address

Bert Weinstein, Esq.
Vice President, Corporate Compliance
Purdue Pharma LP
Stamford, CT
(Co chair)

1:30 p.m.

Re-envisioning the Global Pharmaceutical Enterprise

P. Roy Vagelos, MD
Retired Chief Executive Officer and Chairman, Merck & Co.
Bedminster, NJ

2:15 p.m.

Presentation of PCF First Annual Compliance Best Practice Awards

Categories of Awards in the Large and Small/Medium sectors shall include the following in each sector:

Best Practices in Training
Best Practices in Auditing/Monitoring
Best Practices in Communications
Best Practices Overall

3:00 p.m.

Break

3:30 p.m.

Back by Popular Demand: Compliance Perspectives from The New York Times Magazine Ethicist

Randy Cohen
Author, "The Ethicist" column
The New York Times Magazine
New York, NY

4:30 p.m.

Pharma Congress Hypothetical Compliance Vignettes and Response by Panel of Compliance Experts

Keith M. Korenchuk, JD, MPH
Covington & Burling LLC
Washington, DC
(Co moderator)

Michael Shaw
Deputy Compliance Officer
Novartis Pharmaceuticals Corporation
East Hanover, NJ
(Co moderator)

Expert Panel:

6:00 p.m.

Adjournment and Company Best Auditing, Monitoring and Investigations Policy and Procedure Poster Board and Exchange Reception

The Pharma Congress Wednesday Networking Reception will feature the exchange and presentation of company best practice policy and procedures at poster boards throughout the Pharma Congress Exhibit Hall.

Participating Companies: